Study on Corruption in the Healthcare Sector : HOME/2011/ISEC/PR/047-A2
| Year of publication: |
2013-10-01
|
|---|---|
| Institutions: | Europäische Kommission / Generaldirektion Inneres ; ECORYS (contributor) ; EHFCN (contributor) |
| Subject: | Betrug | fraud | EU | Gesundheitsversorgung | health care | Korruption | corruption |
- Executive summary
- 1 Introduction
- 1.1 Research objectives
- 1.2 Research approach
- 1.3 Terminology
- 1.4 Legal context
- 1.5 Structure of this report
- 2 Healthcare and corruption
- 2.1 Introduction
- 2.2 Informal payments
- 2.3 Medical devices
- 2.4 Pharmaceuticals
- 3 Typologies of healthcare corruption
- 3.1 Introduction
- 3.2 Towards a corruption-in-healthcare typology
- 3.3 Bribery in medical service delivery
- 3.4 Procurement corruption
- 3.5 Improper marketing relations
- 3.6 Misuse of (high level) positions
- 3.7 Undue reimbursement claims
- 3.8 Fraud and embezzlement
- 3.9 Misuse of legal rights
- 4 Policies and practices
- 4.1 Introduction
- 4.2 Generic policies and practices
- 4.3 Control and sanctioning
- 4.4 Bribery in medical service delivery
- 4.5 Procurement corruption
- 4.6 Improper marketing relations
- 4.7 Critical patient, pressure group and media involvement
- 4.8 Findings
- 5 Conclusions and recommendations
- Annex A 86 cases of corruption in health
- Annex B Eurobarometer perceptions
- Annex C EU 28 MS research
- Annex D Country reports
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- The Netherlands
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- United Kingdom
- Annex E Country profile template
Persistent link: https://www.econbiz.de/10010528081